{"slug":"registry-umin","tag":"registry:umin","variants":["registry:umin"],"description":"No description yet","count":1,"kinds":{"trial":1},"related":[],"records":[{"id":"ascot-jcog1202","kind":"trial","name":"ASCOT (JCOG1202)","route":"/trials/ascot-jcog1202/","status":"positive","tldr":"In Japan, six months of the oral chemotherapy S-1 after surgery for bile duct, gallbladder or ampullary cancer improved three-year survival from 68 to 77 percent. S-1 is not licensed for this use in the UK or Europe, so the result cannot be applied directly to NHS patients."}]}